Forskning ved Københavns Universitet - Københavns Universitet

Forside

Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor Antagonist

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

The most common solid tumors show intrinsic multidrug resistance (MDR) or inevitably acquire such when treated with anticancer drugs. In this work, we describe the discovery of a peripherally restricted, potent, competitive NMDA receptor antagonist 1l by a structure-activity study of the broad-acting ionotropic glutamate receptor antagonist 1a. Subsequently, we demonstrate that 1l augments the cytotoxic action of sorafenib in murine hepatocellular carcinoma cells. The underlying biological mechanism was shown to be interference with the lipid signaling pathway, leading to reduced expression of MDR transporters and thereby an increased accumulation of sorafenib in the cancer cells. Interference with lipid signaling pathways by NMDA receptor inhibition is a novel and promising strategy for reversing transporter-mediated chemoresistance in cancer cells.

OriginalsprogEngelsk
TidsskriftJournal of Medicinal Chemistry
Vol/bind60
Udgave nummer23
Sider (fra-til)9885-9904
Antal sider20
ISSN0022-2623
DOI
StatusUdgivet - 14 dec. 2017

ID: 186867038